250 related articles for article (PubMed ID: 9662248)
1. Elevated pretreatment serum levels of soluble vascular cell adhesion molecule 1 and lactate dehydrogenase as predictors of survival in cutaneous metastatic malignant melanoma.
Franzke A; Probst-Kepper M; Buer J; Duensing S; Hoffmann R; Wittke F; Volkenandt M; Ganser A; Atzpodien J
Br J Cancer; 1998 Jul; 78(1):40-5. PubMed ID: 9662248
[TBL] [Abstract][Full Text] [Related]
2. Serum adhesion molecules and interleukin-2 receptor as markers of tumour load and prognosis in advanced cutaneous melanoma.
Vuoristo MS; Laine S; Huhtala H; Parvinen LM; Hahka-Kemppinen M; Korpela M; Kumpulainen E; Kellokumpu-Lehtinen P
Eur J Cancer; 2001 Sep; 37(13):1629-34. PubMed ID: 11527688
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment serum interleukin-6 concentration as a prognostic factor of overall survival in metastatic malignant melanoma patients treated with biochemotherapy: a retrospective study.
Soubrane C; Rixe O; Meric JB; Khayat D; Mouawad R
Melanoma Res; 2005 Jun; 15(3):199-204. PubMed ID: 15917702
[TBL] [Abstract][Full Text] [Related]
4. Elevated serum levels of S100 and survival in metastatic malignant melanoma.
Buer J; Probst M; Franzke A; Duensing S; Haindl J; Volkenandt M; Wittke F; Hoffmann R; Ganser A; Atzpodien J
Br J Cancer; 1997; 75(9):1373-6. PubMed ID: 9155061
[TBL] [Abstract][Full Text] [Related]
5. Quantitative detection of soluble adhesion molecules in sera of melanoma patients correlates with clinical stage.
Schadendorf D; Diehl S; Zuberbier T; Schadendorf C; Henz BM
Dermatology; 1996; 192(2):89-93. PubMed ID: 8829517
[TBL] [Abstract][Full Text] [Related]
6. Prognostic score for patients with advanced melanoma treated with ipilimumab.
Diem S; Kasenda B; Martin-Liberal J; Lee A; Chauhan D; Gore M; Larkin J
Eur J Cancer; 2015 Dec; 51(18):2785-91. PubMed ID: 26597444
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-6 and its surrogate C-reactive protein are useful serum markers for monitoring metastasized malignant melanoma.
Deichmann M; Benner A; Waldmann V; Bock M; Jäckel A; Näher H
J Exp Clin Cancer Res; 2000 Sep; 19(3):301-7. PubMed ID: 11144523
[TBL] [Abstract][Full Text] [Related]
8. D-dimers in malignant melanoma: Association with prognosis and dynamic variation in disease progress.
Desch A; Gebhardt C; Utikal J; Schneider SW
Int J Cancer; 2017 Feb; 140(4):914-921. PubMed ID: 27813063
[TBL] [Abstract][Full Text] [Related]
9. Clinical use of p-proteasome in discriminating metastatic melanoma patients: comparative study with LDH, MIA and S100B protein.
Henry L; Fabre C; Guiraud I; Bastide S; Fabbro-Peray P; Martinez J; Lavabre-Bertrand T; Meunier L; Stoebner PE
Int J Cancer; 2013 Jul; 133(1):142-8. PubMed ID: 23238767
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of the soluble adhesion molecules in patients with malignant melanoma.
Yasasever V; Tas F; Duranyildiz D; Camlica H; Kurul S; Dalay N
Pathol Oncol Res; 2000; 6(1):42-5. PubMed ID: 10749587
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in metastatic melanoma patients treated with biochemotherapy and maintenance immunotherapy.
Minor DR; Moore D; Kim C; Kashani-Sabet M; Venna SS; Wang W; Boasberg P; O'Day S
Oncologist; 2009 Oct; 14(10):995-1002. PubMed ID: 19776094
[TBL] [Abstract][Full Text] [Related]
12. Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer Stage IV Melanoma: results of the EORTC 18951 Biochemotherapy Trial.
Schmidt H; Suciu S; Punt CJ; Gore M; Kruit W; Patel P; Lienard D; von der Maase H; Eggermont AM; Keilholz U; ;
J Clin Oncol; 2007 Apr; 25(12):1562-9. PubMed ID: 17443000
[TBL] [Abstract][Full Text] [Related]
13. Elevated serum levels of soluble adhesion molecules predict death in pre-dialysis patients: association with malnutrition, inflammation, and cardiovascular disease.
Stenvinkel P; Lindholm B; Heimbürger M; Heimbürger O
Nephrol Dial Transplant; 2000 Oct; 15(10):1624-30. PubMed ID: 11007832
[TBL] [Abstract][Full Text] [Related]
14. Serum interleukin-6 as a prognostic biomarker in patients with metastatic melanoma.
Hoejberg L; Bastholt L; Johansen JS; Christensen IJ; Gehl J; Schmidt H
Melanoma Res; 2012 Aug; 22(4):287-93. PubMed ID: 22617301
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of in vivo soluble cell adhesion molecules in metastatic renal cell carcinoma.
Hoffmann R; Franzke A; Buer J; Sel S; Oevermann K; Duensing A; Probst M; Duensing S; Kirchner H; Ganser A; Atzpodien J
Br J Cancer; 1999 Apr; 79(11-12):1742-5. PubMed ID: 10206286
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of sICAM-1, sVCAM-1, and sE-Selectin levels in patients with metastatic breast cancer receiving high-dose chemotherapy.
Bewick M; Conlon M; Lee H; Parissenti AM; Zhang L; Glück S; LaFrenie RM
Stem Cells Dev; 2004 Jun; 13(3):281-94. PubMed ID: 15186724
[TBL] [Abstract][Full Text] [Related]
17. Elevated serum level of YKL-40 is an independent prognostic factor for poor survival in patients with metastatic melanoma.
Schmidt H; Johansen JS; Gehl J; Geertsen PF; Fode K; von der Maase H
Cancer; 2006 Mar; 106(5):1130-9. PubMed ID: 16456816
[TBL] [Abstract][Full Text] [Related]
18. Soluble adhesion molecule profiling in preoperative infants with biliary atresia.
Davenport M; Gonde C; Narayanaswamy B; Mieli-Vergani G; Tredger JM
J Pediatr Surg; 2005 Sep; 40(9):1464-9. PubMed ID: 16150350
[TBL] [Abstract][Full Text] [Related]
19. A distinct profile of serum levels of soluble intercellular adhesion molecule-1 and intercellular adhesion molecule-3 in mycosis fungoides and Sézary syndrome.
López-Lerma I; Estrach MT
J Am Acad Dermatol; 2009 Aug; 61(2):263-70. PubMed ID: 19615537
[TBL] [Abstract][Full Text] [Related]
20. Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients.
Kos J; Stabuc B; Schweiger A; Krasovec M; Cimerman N; Kopitar-Jerala N; Vrhovec I
Clin Cancer Res; 1997 Oct; 3(10):1815-22. PubMed ID: 9815568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
